Immuneering to bolster cancer pipeline, expand services unit with $17M series A
Eleven-year-old Immuneering Corp. has raised its first venture round as it gears up to send its inaugural program to the clinic to treat cachexia in cancer patients and extensively expand its pipeline.
Developing A Smart Inhaler For Optimal Drug Delivery
Historically, inhalation drug delivery was limited to the treatment and management of respiratory diseases, such as asthma or chronic obstructive pulmonary disease. However, this delivery approach has broadened as an alternative treatment option for a number of systemic diseases,[i] including endocrine and neurological diseases, which could benefit from the frequent pulsatile administration afforded by an inhaled delivery option.
Synaptive Medical announces close of $25M preferred share financing to expand global footprint
Synaptive Medical Inc. has completed the first round of a new preferred equity investment totaling $25 million led by Guelph-Ontario-based Linamar Corp., which also entered into a manufacturing agreement with Synaptive, and Calgary’s Audible Capital Corp.
Cleveland company developing technology to help patients with diabetes
As the cost of life-saving insulin soars for people with diabetes, a Cleveland company is developing nanotechnology that could help. The technology, from Diasome, makes insulin more effective in the body so less is needed to regulate blood sugar. Insulin costs for patients with type one diabetes doubled between 2012 and 2016, according to the nonprofit Health Care Cost Institute.
Bucks County medical device firm lands $20M credit deal from Silicon Valley Bank
Bucks County medical device company Orchestra BioMed said Tuesday it has entered into a $20 million credit agreement with Silicon Valley Bank. This deal provides Orchestra BioMed with an initial amount of up to $10 million it can use for development and general corporate expenditures during the next 12 months. The remaining will be available to the company if it hits certain undisclosed product development milestones.
Surprise man battling rare disease helping researchers come up with treatment
A man who lives in Surprise is helping researchers come up with a treatment for a rare disease that he was diagnosed with 20 years ago. Jerry DeVries, now 61, is possibly the oldest living person with Proteus Syndrome.
Driving Drug Discovery Using Patients’ Immune Response
Rather than picking targets based on conventional approaches, Immunome is letting a patient‘s ability to fight the disease guide target selection and therapy identification.
IPO Window, Recession, Trade War & More — 5 Biopharma Finance Experts Share Their Perspectives For 2020
We are always acutely aware of investors’ appetite to participate in financing deals, and to what degree. There has been a lot of chatter about the “window closing” in 2020, but from what we can see, financing deals for good science and novel ideas are still getting done, and we’re cautiously optimistic that the environment will remain open to healthy deals at the right valuations.
